CEL-SCI Corporation (CVM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated December 29, 2024, details a material definitive agreement entered into by CEL-SCI Corporation, a Colorado corporation. The report covers the pricing and closing of a public offering of common stock and pre-funded warrants.
Key Financial Metrics and Transaction Details
- Offering Structure: Sale of 7,552,500 shares of common stock at $0.31 per share and pre-funded warrants to purchase up to 8,577,500 shares at $0.3099 per warrant.
- Gross Proceeds: Approximately $5,000,000 (exclusive of pre-funded warrant exercise price and before deducting fees).
- Placement Agent Fees: 7.0% of gross proceeds plus reimbursement of expenses up to $110,000.
- Use of Proceeds: Funding continued development of Multikine, general corporate purposes, and working capital.
- Transaction Status: The offering closed on December 31, 2024.
Note: This filing does not provide revenue, profit, cash flow, margin, or debt metrics for the company's operations. It focuses solely on the capital raise transaction.
Material Changes and Agreements
- Lock-Up Agreements: The Company agreed not to issue or announce the issuance of common stock or convertible securities for 30 days from December 29, 2024.
- Insider Lock-Up: Directors and officers agreed not to sell or transfer Company securities for 45 days from December 29, 2024.
- Registration Basis: Securities were sold pursuant to an effective Form S-3 registration statement (No. 333-265995) declared effective on July 15, 2022.
Outlook, Risks, and Management Commentary
Management intends to utilize the net proceeds to advance the development of Multikine. The filing includes standard forward-looking statements cautioning that actual results may differ materially from projections. Specific risks and uncertainties are referenced in the Company's prospectus supplement filed on December 30, 2024, and its Annual Report on Form 10-K for the fiscal year ended September 30, 2023.
Key Facts for Investor Verification
- Verify the final net proceeds after deducting the 7% placement fee and the $110,000 expense cap.
- Confirm the total dilution impact from the issuance of 7,552,500 shares plus the potential 8,577,500 shares from pre-funded warrants.
- Review the full text of the Placement Agency Agreement (Exhibit 1.1) for additional covenants or termination provisions.
- Check the Company's cash position and burn rate in the most recent 10-K to assess runway extension provided by the $5 million gross raise.